CLL Research Updates From ASH 2023
Experts discussed the latest updates from the 2023 American Society of Hematology (ASH) meeting.
CLL Global Virtual Town Hall: February 7, 2024
Experts discussed the latest advances in CLL clinical trials highlighted at the 2021 American Society of Hematology (ASH) meeting, the world’s premier conference in hematology.
Let’s Talk CLL! Questions & Answers
Q&A from the Let’s Talk CLL Town Hall.
Let’s Talk CLL! Optimized Care & Limiting Side Effects
Optimized Care & Limiting Side Effects from the Let’s Talk CLL! Town Hall.
Let’s Talk CLL! Vaccines & CLL
Vaccines & CLL from the Let’s Talk CLL! Town Hall.
Let’s Talk CLL! The Latest Treatments & Clinical Trials
The Latest Treatments & Clinical Trials from the Let’s Talk CLL! Town Hall.
Is There Hope for a CLL Cure?
Dr. Michael Keating, Founder, CLL Global Research Foundation Jeff Folloder, Moderator and CLL patient advocate Experts responded to listener questions during our January 13, 2023 virtual town hall. Watch the full webinar here. Jeff: Is there a hope for a cure for CLL? Dr. Keating: Well, I think it’s very difficult because to say that you’ve […]
Does CLL Treatment Cause CLL Cells to Become Stronger and Harder to Treat?
Jeff Folloder, Moderator and CLL patient advocate Dr. William Wierda, President & CEO, CLL Global Research Foundation Experts responded to listener questions during our January 13, 2023 virtual town hall. Watch the full webinar here. Jeff: Dr. Wierda, Matt would like to know do CLL active cells become stronger with each treatment, effectively making them harder […]
When Will CAR T-Cell Therapy Be an Option for CLL Patients?
Dr. William Wierda, President & CEO, CLL Global Research Foundation Jeff Folloder, Moderator and CLL patient advocate Experts responded to listener questions during our January 13, 2023 virtual town hall. Watch the full webinar here. Transcript: Jeff Folloder: The first question comes from Esther. She would like to know when will CAR T be a […]
CLL Global Virtual Town Hall: January 13, 2023
Experts shared the latest information on emerging CLL research and clinical trials, including news from the 2022 American Society of Hematology (ASH) annual conference and responded to audience questions.